← Back to Search

TEAMWork App for Breast Cancer

N/A

Recruiting

Led By Victoria Blinder, M.D., M.Sc.

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient Usability Testing Inclusion Criteria: The ability to give informed consent in English or Spanish

RCT Inclusion Criteria: Female

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial is testing an app to help breast cancer patients keep their jobs while receiving treatment.

Who is the study for?

This trial is for breast cancer patients aged 18-64, who are currently employed and about to start or already receiving chemotherapy for stage I-III breast cancer. They must be able to give consent in English or Spanish, have a smartphone, and be comfortable using it. Excluded are those with stage 0 (DCIS only) or stage IV (metastatic) breast cancer, those with recurrent metastatic disease, and participants in related social determinants of health studies.Check my eligibility

What is being tested?

The study tests the TEAMWork App against an information booklet. The app aims to help breast cancer patients manage their employment during treatment by providing advice on communicating with employers and medical staff about work-related needs.See study design

What are the potential side effects?

Since this trial involves the use of a mobile app rather than medication, traditional side effects aren't expected. However, users may experience stress or discomfort when discussing sensitive topics prompted by the app's content.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can give informed consent in English or Spanish.

Select...

I am a female.

Select...

I am at least 18 years old.

Select...

I can give informed consent in English or Spanish.

Select...

I have finished chemotherapy for early to mid-stage breast cancer.

Select...

I am 18 years old or older.

Select...

I can give informed consent in English or Spanish.

Select...

I have been diagnosed with cancer.

Select...

I am between 18 and 64 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

number of participants still employed

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TEAMWork AppExperimental Treatment1 Intervention

The 2-pronged approach of the intervention is operationalized through 2 menus, 1 focused on interactions with the employer and the other with the clinic team. Each menu has a list of features from which participants can choose to learn about a particular topic. A "My notes" button allows participants to take notes directly on the app. These notes will not be available to the research team, such that participants may use the tool without concerns about privacy. The workplace accommodations menu includes sample videos using trained actors to demonstrate how to approach an employer to request accommodations. Additional features include suggestions for accommodations that may be helpful, templates for letters participants can use when requesting accommodations, links to relevant websites, information about legal protections, and contact information for lawyers and firms that provide pro bono assistance.

Group II: Information Booklet (control)Active Control1 Intervention

Participants will receive a booklet that includes the information in the app that can practicably be converted to paper. These participants will not have access to the multimedia aspects of the intervention, such as the videos, but they will have all of the relevant information in the app described above, including suggestions for accommodations, written templates for letters, links to websites, information about legal protections, and contact information for pro bono legal assistance. The booklet will also contain information about chemotherapy, radiation therapy and surgery, recommendations for management of common symptoms, and advice for communicating with the clinic team. The information booklet will be provided entirely on paper, although participants may independently access websites recommended in the booklet. The booklet content will mirror the app with regard to cultural responsiveness and appropriateness for different job types and characteristics.

0 / 9Eligibility criteria met

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,936 Previous Clinical Trials

588,352 Total Patients Enrolled

202 Trials studying Breast Cancer

80,557 Patients Enrolled for Breast Cancer

Victoria Blinder, M.D., M.Sc.Principal InvestigatorMemorial Sloan Kettering Cancer Center

1 Previous Clinical Trials

935 Total Patients Enrolled

1 Trials studying Breast Cancer

935 Patients Enrolled for Breast Cancer

Media Library

TEAMWork App Clinical Trial Eligibility Overview. Trial Name: NCT03572374 — N/A

Breast Cancer Research Study Groups: Information Booklet (control), TEAMWork App

Breast Cancer Clinical Trial 2023: TEAMWork App Highlights & Side Effects. Trial Name: NCT03572374 — N/A

TEAMWork App 2023 Treatment Timeline for Medical Study. Trial Name: NCT03572374 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many medical facilities are overseeing the implementation of this clinical trial?

"Potential patients have 14 different locations to choose from, including Memorial Sloan Kettering Westchester in Harrison and the Ralph Lauren Center for Cancer Care and Prevention in Uniondale. Additionally, there are 11 other facilities available."

Answered by AI

How many participants are currently partaking in this medical experiment?

"Yes, according to clinicaltrials.gov this trial is actively searching for participants. It was first posted on June 7th 2018 and amended on October 26th 2022 with the aim of enrolling 546 patients across 14 sites."

Answered by AI

Could you please tell me if recruitment is still underway for this trial?

"The clinical trial is currently recruiting, with the first posting on June 7th 2018 and a recent update on October 26th 2022. This information can be found in clinicialtrials.gov."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

2018. "Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03572374.

All > Breast Cancer New York